Harm Reduction: A New Direction for Drug Policies and Programs
Author: Patricia G. Erickson, Diane M. Riley, Yuet W. Cheung & Pat A. O’Hare (Editor) Publisher: University of Toronto Press Published: 1997 Pages: 476 More DetailsCaption
“A global handbook on policies that curb harm—not punishment—for substance use.”
Synopsis
Harm Reduction: A New Direction for Drug Policies and Programs is a landmark volume that redefines the global conversation on drug use, addiction, and public health. Edited by Patricia G. Erickson, Diane M. Riley, Yuet W. Cheung, and Pat A. O’Hare, this comprehensive work brings together over thirty contributors from around the world to offer a multidimensional analysis of harm reduction as both a public health philosophy and a practical policy approach.
Emerging from seven international harm reduction conferences, the book presents a global synthesis of research, case studies, and policy models that challenge traditional punitive drug strategies. Instead of focusing on eradication or criminalization, harm reduction seeks to minimize the negative health, social, and economic consequences associated with substance use—whether the drug in question is legal, illegal, or somewhere in between.
The volume is structured thematically and geographically, with contributions covering North America, Europe, Asia, and Australia. It features in-depth explorations of:
- Needle exchange and syringe distribution programs as key tools to reduce HIV/AIDS and hepatitis transmission.
- Methadone and buprenorphine maintenance therapy for opioid dependence.
- Safe injection sites, peer outreach models, and the role of formerly incarcerated people in prevention.
- Alcohol harm reduction for youth and indigenous communities.
- Harm reduction in prisons and among street-involved populations.
- Women’s health, reproductive rights, and drug policy, addressing gender-specific vulnerabilities and systemic neglect.
- Policy analysis, from human rights frameworks to practical public health implementation.
The editors also interrogate the moral, ethical, and legal dimensions of harm reduction, examining how international drug control conventions and national legislation shape—or hinder—local responses. Several chapters investigate tensions between abstinence-based treatment ideologies and pragmatic harm reduction models, highlighting the challenges of shifting public discourse and institutional resistance.
With its interdisciplinary lens, the book draws from public health, law, sociology, criminology, and medicine, offering tools for practitioners, scholars, and activists alike. It calls on policymakers to move beyond zero-tolerance mindsets and instead adopt evidence-based strategies rooted in compassion, dignity, and public health efficacy.
